EP0258692A2 - Surgical prothesis - Google Patents
Surgical prothesis Download PDFInfo
- Publication number
- EP0258692A2 EP0258692A2 EP87111585A EP87111585A EP0258692A2 EP 0258692 A2 EP0258692 A2 EP 0258692A2 EP 87111585 A EP87111585 A EP 87111585A EP 87111585 A EP87111585 A EP 87111585A EP 0258692 A2 EP0258692 A2 EP 0258692A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- lactide
- laminate
- polymer
- poly
- alumina
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/148—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/12—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L31/125—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/12—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L31/125—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L31/127—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix containing fillers of phosphorus-containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Definitions
- This invention relates to surgical structural elements consisting of bioabsorbable or semi-bioabsorbable composites, as well as to products and applications using these materials.
- Such surgical structural devices may include plates, screws, nails, pegs, rods, pins and any other device which would require a bioabsorbable material with relatively high rigidity and strength.
- internal bone fixation is an established and clinically used technique.
- the two major types of internal fixation devices are bone plates and intramedullary rods.
- the particular form intended for this invention is as an internal bone fixation plate.
- Bone plates are applicable to a large variety of bones including load bearing as well as non-load bearing bones. Presently, more long bone fixations are done with intramedullary rods. Both of these devices are traditionally made of metal, e.g. stainless steel 316. There are two major disadvantages, however, associated with the presently used metal plates:
- the stiffness of a bone plate can be made essentially equal to the modulus of cortical bone. If the low stiffness bone plate is also bioabsorbable, it does not have to be surgically removed. Thus the need for a second surgical procedure is eliminated.
- Bioabsorbable materials with an initial modulus and strength at or near those of cortical bone are useful as internal bone fracture fixation devices for load bearing as well as non-load bearing bones.
- the completely bioabsorbable or semi-absorbable composites of this invention are superior in mechanical properties and in biological behavior to the stainless steel devices presently used.
- the mechanical properties of these composites can be tailored to the specific end-use application.
- the devices of this invention will gradually lose their mechanical properties and will ultimately fully or partially disappear.
- a bioabsorbable device with an adjustable initial modulus which can be set at, above or below the modulus of bone, and which loses properties at a controllable, predictable rate after implantation has been invented.
- the device may consist of a poly(l-lactide) matrix reinforced with a-alumina fibers (DuPont Fiber FP TM ) or aramid fibers (DuPont Kevlar TM ), or it may consist of a high molecular weight poly (dl-lactide) matrix reinforced with ultra high modulus polyethylene fibers (Allied A-900 TM , Allied Corp., N.J., U.S.A. These three composite systems are examples of semi--absorbable surgical devices.
- This invention uses a combination of materials which may consist of a bioabsorbable polymer and a reinforcement fiber (which may or may not be bioabsorbable), or a bioabsorbable polymer and a bioabsorbable filler.
- the component materials are combined in such a way as to have bending, axial and torsional stiffness and strength suitable for the biomechanical demands placed upon it.
- the material will, subsequent to implantation, gradually lose both stiffness and strength according to the time frame for which useful properties are required.
- the material will ultimately be completely or partially absorbed by the body, any residue being both inert in the body and bereft of significant mechanical properties. No surgical procedure to remove the device would be required.
- a bone fixation device has been invented.
- the device comprises an absorbable polymer and the polymer is obtained from the polymerization of 1-lactide, and a reinforcement material.
- the polymer is obtained from the copolymerization of 1-lactide and dl-lactide. In another embodiment the polymer is obtained from the copolymerization of 1-lactide and glycolide. In a further embodiment, the polymer is obtained from the copolymerization of 1-lactide and 1,3-dioxan-2-one.
- the reinforcement material is a filler.
- the filler is in particulate form.
- the particulate filler is hydroxyapatite.
- the filler is selected from the group consisting of tricalcium phosphate, hydroxyapatite, and a mixture thereof.
- the reinforcement material is manufactured from a plurality of fibers.
- the fiber material is selected from the group consisting of alumina, poly ( E -phenylene terephthalamide), polyethylene terephthalate, and ultra high modulus polyethylene.
- the fiber is poly(p-phenylene terephthalamide).
- the fiber is polyethylene terephthalate.
- the fiber is alumina.
- the fiber is alpha alumina.
- the alternative device comprises an absorbable polymer and a reinforcement material manufactured from a plurality of ultra high modulus polyethylene fibers.
- the absorbable polymer is obtained from the polymerization of dl-lactide.
- the device comprises an absorbable polymer, said polymer obtained from the copolymerization of 1-lactide, dl-lactide, and a monomer selected from the group consisting of glycolide, 1, 3-dioxan-2-one, and p-dioxanone and a reinforcement material.
- the monomer is glycolide.
- the monomer is 1,3-dioxan--2-one.
- the reinforcement material is a filler.
- the filler is in particulate form.
- the particulate fiber is hydroxyapatite.
- the filler is selected from the group consisting of tricalcium phosphate, hydroxyapatite, and a mixture thereof.
- the reinforcement material is manufactured from a plurality of fibers selected from the group consisting of alumina, poly(p-phenylene terephthalamide), polyethylene terephthalate, and ultra high modulus polyethylene.
- the fiber is alumina.
- the fiber is alpha alumina.
- a laminated bone fixation device has also been invented.
- the device comprises an impregnating agent consisting of an absorbable polymer matrix.
- the polymer is obtained from the polymerization of 1-lactide.
- the matrix has an inherent viscosity of about 1.5 to 3.5 dl/g (0.5 g/dl in CHC1 3 ).
- the device also comprises a nonabsorbable reinforcement material.
- the reinforcement material consists essentially of at least one alumina fiber.
- the device has a flexural strength of about 10,000 to 25,000 psi; a flexural modulus of about I X 10 6 to 5x10 6 psi; a loss of about 30% of initial flexural strength during 3 months in vivo and 60% during 6 months in vivo; and a loss of about 25% of initial flexural modulus during 3 months in vivo and 45% during 6 months in vivo.
- the reinforcement material is a plurality of alpha alumina fibers. In a specific embodiment, the reinforcement material comprises about 10 to 60 volume percent of said fibers. In a more specific embodiment, the device comprises about 15 to 40 percent of said fibers. In another embodiment, the device has a flexural strength of about 15,000 to 25,000 psi. In a further embodiment, the device has a flexural modulus of up to about 3x106 psi.
- Figures 4 to 6 show the bone fixation device.
- the device can be manufactured without undue experimentation by methods known in the prior art, e.g. by compression molding.
- the device can be attached to a bone by any means presently known or obvious to a person having ordinary skill in the art, for example by fastening with screws, staples and the like, or by bonding, for example, by gluing the device to the bone.
- FIGs 4 to 6 show holes 2 which are used to each accommodate a screw 5 (shown in Figure 7). To accommodate the screw head, a plurality of holes 2 are countersunk 3 in the device 1.
- FIG 7 the preferred relationship of the device 1 to a mammalian bone 4 fracture is shown. Under many circumstances, the configuration shown in Figure 7 will allow the best possible chance for uniform healing of the fracture in the bone 4.
- Poly(1-lactide)-Alumina Fiber Laminate The laminate was formed from poly(l-lactide) of inherent viscosity 2.68 dl/g (0.5 g/dl in CHC1 3 , after consolidation) and a fabric made from alumina fiber. Poly(l-lactide) was melt pressed into 4" by 4" square films, two films of 0.005" and two films of 0.023" thickness. The laminate was formed by stacking the films and fabric in alternating layers. Three plies of fabric were used. The 0.005" thick films were used for the -two outside layers. The laminate was consolidated by heating to 200 0 C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 19% alumina fabric by volume. The laminate had the following mechanical properties:
- This material is of particular interest due to it's superior in vivo performance in subcutaneous rabbit implant experiments.
- the degradation of this material in vivo is shown in Figures 1-3.
- Figures 1 and 2 show the physical property degradation profile and
- Figure 3 shows the molecular weight degradation profile, as contrasted with materials used in prior art bone fixation devices.
- the initial properties of this composite system can be varied over a wide range by varying fiber loading.
- the degradation profile can be altered by varying the initial molecular weight of the matrix polymer.
- Poly(1-lactide)-Kevlar Laminate A laminate was formed which consisted of a poly(l-lactide) of inherent viscosity 1.00 dl/g (0.5 g/dl in CHCl 3 , before consolidation) and a satin weave Kevlar 49 fabric. The polymer was dissolved in methylene chloride at a concentration of 5% (w/v). Kevlar fabric was immersed in the solution to form a prepreg of 22% poly(l-lactide) by weight. Poly(l-lactide) was melt pressed into films approximately 0.004" thick. Seven polymer films and six plies of prepreg were laid-up in alternating layers. The laminate was consolidated by heating at 200°C in a vacuum bag and compressing to a thickness of 1/16". The resulting laminate was 49% Kevlar by volume. The laminate had the following mechanical properties:
- Poly(1-lactide)-Alumina Laminate A laminate was formed which consisted of a poly(1-lactide) of inherent viscosity 1.64 dl/g (0.5 g/dl in CHC1 3 , after consolidation) and a fabric made from alumina fiber. Poly(1-lactide) was reprecipitated from a chloroform solution into methanol. The dried precipitate was pressed into 4" by 4" square mats, two mats of 6.5 g and two mats of 1.2 g. The laminate was formed by stacking the mats and fabric in alternating layers. Three plies of fabric were used. The 1.2 g mats were used for the two outside layers. The laminate was consolidated by heating to 195°C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 17% alumina fabric by volume. The laminate had the following mechanical properties:
- Poly(1-lactidey-Alumina Laminate A laminate was formed which consisted of a poly(1-lactide) of inherent viscosity 2.65 dl/g (0.5 g/dl in CHC1 3 , after consolidation) and a fabric made from alumina fiber. Poly(1-lactide) was reprecipitated from a chloroform solution into methanol. The dried precipitate was pressed into 4" by 4" square mats, two mats of 6.5 g and two mats of 1.2 g. The laminate was formed by stacking the mats and fabric in alternating layers. Three plies of fabric were used. The 1.2 g mats were used for the two outside layers. The laminate was consolidated by heating to 195°C in a vacuum bag and compressing to a-thickness of 1/16". The laminate contained 17% alumina fabric by volume. The laminate had the following mechanical properties:
- Poly(1-lactide)-Alumina Laminate A laminate was formed which consisted of a poly(l-lactide) of inherent viscosity 4.14 dl/g (0.5 g/dl in CHC1 3 , after consolidation) and a fabric made from alumina fiber. P oly(l-lactide) was reprecipitated from a chloroform solution into methanol. The dried precipitate was pressed into 4" by 4" square mats, two mats of 6.5 g and two mats of 1.2 g. The laminate was formed by stacking the mats and fabric in alternating layers. Three plies of fabric were used. The 1.2 g mats were used for the two outside layers. The laminate was consolidated by heating to 195 0 C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 17% alumina fabric by volume. The laminate had the following mechanical properties:
- Poly(1-lactide)-Alumina Laminate A laminate was formed which consisted of a poly(l-lactide) of inherent viscosity 2.64 dl/g (0.5 g/dl in CHC1 3 , before consolidation) and a fabric made from alumina fiber. Poly(l-lactide) was melt pressed into 4" by 4" square films, two films of 0.005" and one film of 0.045" thickness. The laminate was formed by stacking the films and fabric in alternating layers. Two plies of fabric were used. The 0.005" films were used for the two outside layers. The laminate was consolidated by heating to 200°C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 13% alumina fabric by volume. The laminate had the following mechanical properties:
- Poly(1-lactide)-Alumina Laminate A laminate was formed which consisted of a poly(l-lactide) of inherent viscosity 2.64 dl/g (0.5 g/dl in CHC13, before consolidation) and a fabric made from alumina fiber. Poly(l-lactide) was melt pressed into 4" by 4" square films, two films of 0.005" and two films of 0.023" thickness. The laminate was formed by stacking the films and fabric in alternating layers. Three plies of fabric were used. The 0.005" films were used for the two outside layers. The laminate was consolidated by heating to 200°C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 19% alumina fabric by volume. The laminate had the following mechanical properties:
- Poly(1-lactide)-Alumina Laminate A laminate was formed which consisted of a poly(l-lactide) of inherent viscosity 2.64 dl/g (0.5 g/dl in CHC1 3 , before consolidation) and a fabric made from alumina fiber. Poly(1-lactide) was melt pressed into 4" by 4" square films, two films of 0.005" and three films of 0.015" thickness. The laminate was formed by stacking the films and fabric in alternating layers. Four plies of fabric were used. The 0.005" films were used for the two outside layers. The laminate was consolidated by heating to 200°C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 24% alumina fabric by volume. The laminate had the following mechanical properties:
- Poly(1-lactide)-Alumina Laminate A laminate was formed which consisted of a poly(l-lactide) of inherent viscosity 2.64 dl/g (0.5 g/dl in CHCl 3 , before consolidation) and a fabric made from alumina fiber. Poly(l-lactide) was melt pressed into 4" by 4" square films, two films of 0.005" a.nd four films of 0.008" thickness. The laminate was formed by stacking the films and fabric in alternating layers. Five plies of fabric were used. The 0.005" films were used for the two outside layers. The laminate was consolidated by heating to 200°C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 30% alumina fabric by volume. The laminate had the following mechanical properties:
- Poly(1-lactide)-Alumina Laminate A laminate was formed by impregnating 1/2" chopped alumina fiber with poly(l-lactide). The polymer had an inherent viscosity of 2.64 dl/g (0.5 g/dl in CHC1 3 , before consolidation). The impregnation was accomplished by dissolving the polymer in chloroform (10 g/dl) followed by stirring in the chopped fiber. The mixture was then dried under vacuum to constant weight. The impregnated fiber was consolidated using vacuum and compression at 200°C, forming a laminate containing 30% alumina by volume. The laminate had the following mechanical properties:
- Poly(dl-lactide)-Polyethylene Laminate A laminate was constructed using Ultra High Modulus Polyethylene (UHMPE) and poly(dl-lactide). The UHMPE fiber was laid-up in unidirectional plies with 0°, 90° orientation. Between each ply, a 0.003" thick film (melt pressed) of poly(dl-lactide) was laid. A film of polymer was placed on the top and the bottom of the lay-up as well. The laminate was consolidated by heating to 120°C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 41% UHMPE by volume. The laminate had the following mechanical properties:
- Poly(1-lactide)-Polyethylene Terephthalate Laminate Poly(l-lactide) with an initial inherent viscosity of 3.63 dl/g (0.5 g/dl in CHC1 3 ) was dissolved in CHC1 3/ ethyl acetate (V/V 9/1), at a concentration of 1 0% (w/v). Polyethylene terephthalate fabric was impregnated by dipping in the solution to a coating level of ⁇ 50% by weight. Six plies of this prepreg were then consolidated in a heated hydraulic press at 180 * C for 3 minutes with about 1500 psi pressure. The resulting laminate had a flexural modulus of 0.43 X 10 6 psi.
- Poly-(1-lactide)-Hydroxyapatite Composite Poly-(1-lactide) was prepared by charging 100 g of 1-lactide, 15.5 ul (0.01 mole %) lauryl alcohol and 15.6 mg (0.01 mole %) stannous chloride dihydrate into a stirred reactor at 200°C. When the power drain on the stirring motor reached a maximum, 45 g of hydroxyapatite (Ca 10 (OH) 2 (PO 4 ) 6 , Mallinckrodt) was added. The composite was discharged after it appeared homogeneous (about 5 min.). The composite contained about 14% hydroxyapatite by volume.
- the flexural properties of a compression molded plaque were:
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Vascular Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Prostheses (AREA)
Abstract
Description
- This invention relates to surgical structural elements consisting of bioabsorbable or semi-bioabsorbable composites, as well as to products and applications using these materials. Such surgical structural devices may include plates, screws, nails, pegs, rods, pins and any other device which would require a bioabsorbable material with relatively high rigidity and strength.
- The use of internal bone fixation is an established and clinically used technique. The two major types of internal fixation devices are bone plates and intramedullary rods. The particular form intended for this invention is as an internal bone fixation plate.
- Bone plates are applicable to a large variety of bones including load bearing as well as non-load bearing bones. Presently, more long bone fixations are done with intramedullary rods. Both of these devices are traditionally made of metal, e.g. stainless steel 316. There are two major disadvantages, however, associated with the presently used metal plates:
- 1) Metal plates have a modulus approximately one order of magnitude greater than cortical bone.
- This mismatch in stiffness is known to cause stress protection induced osteoporosis or os- teopenia. The increase in porosity and decrease in cortical wall thickness results in a weakened bone which is prone to refracture once the bone plate is removed.
-
- 2) The metal plates must be removed due to their nonbiodegradable nature coupled with the eventual possibility of corrosion. A second surgical procedure is therefore required which may introduce further complications.
- The use of lower stiffness materials such as nonabsorbable composites and tubular steel have been investigated. However, no human trials of these materials are known.
- Lower stiffness bone fixation devices have advantages over metal plates. For example the stiffness of a bone plate can be made essentially equal to the modulus of cortical bone. If the low stiffness bone plate is also bioabsorbable, it does not have to be surgically removed. Thus the need for a second surgical procedure is eliminated.
- Considerable research has therefore been devoted to the development of low stiffness bone plate materials. The properties which are most desirable in a bone plate are:
- 1) The bone plate should provide a firm fixation of the broken bone to promote union during the early stages of healing.
- 2) Once union has occurred, the load which was initially supported. by the bone plate, would be gradually transferred back to the bone. This would induce the formation of stronger more dense bone at the fracture site thus accelerating the healing process.
- 3) After the bone heals (3 to 6 months after implantation) the bone plate would completely lose its ability to support a load. The bone would then be once again subjected to its normal stresses.
- Bioabsorbable materials with an initial modulus and strength at or near those of cortical bone are useful as internal bone fracture fixation devices for load bearing as well as non-load bearing bones.
- The completely bioabsorbable or semi-absorbable composites of this invention are superior in mechanical properties and in biological behavior to the stainless steel devices presently used. The mechanical properties of these composites can be tailored to the specific end-use application. The devices of this invention will gradually lose their mechanical properties and will ultimately fully or partially disappear.
- A bioabsorbable device with an adjustable initial modulus which can be set at, above or below the modulus of bone, and which loses properties at a controllable, predictable rate after implantation has been invented. The device may consist of a poly(l-lactide) matrix reinforced with a-alumina fibers (DuPont Fiber FPTM) or aramid fibers (DuPont KevlarTM), or it may consist of a high molecular weight poly (dl-lactide) matrix reinforced with ultra high modulus polyethylene fibers (Allied A-900TM, Allied Corp., N.J., U.S.A. These three composite systems are examples of semi--absorbable surgical devices.
- This invention uses a combination of materials which may consist of a bioabsorbable polymer and a reinforcement fiber (which may or may not be bioabsorbable), or a bioabsorbable polymer and a bioabsorbable filler. The component materials are combined in such a way as to have bending, axial and torsional stiffness and strength suitable for the biomechanical demands placed upon it. The material will, subsequent to implantation, gradually lose both stiffness and strength according to the time frame for which useful properties are required. The material will ultimately be completely or partially absorbed by the body, any residue being both inert in the body and bereft of significant mechanical properties. No surgical procedure to remove the device would be required.
- A bone fixation device has been invented. The device comprises an absorbable polymer and the polymer is obtained from the polymerization of 1-lactide, and a reinforcement material.
- In one embodiment, the polymer is obtained from the copolymerization of 1-lactide and dl-lactide. In another embodiment the polymer is obtained from the copolymerization of 1-lactide and glycolide. In a further embodiment, the polymer is obtained from the copolymerization of 1-lactide and 1,3-dioxan-2-one.
- In yet another embodiment, and in combination with any of the above embodiments, the reinforcement material is a filler. In a specific embodiment, the filler is in particulate form. In a more specific embodiment, the particulate filler is hydroxyapatite. In another specific embodiment, the filler is selected from the group consisting of tricalcium phosphate, hydroxyapatite, and a mixture thereof.
- In a still further embodiment, and in combination with any of the above polymer embodiments, the reinforcement material is manufactured from a plurality of fibers. The fiber material is selected from the group consisting of alumina, poly (E-phenylene terephthalamide), polyethylene terephthalate, and ultra high modulus polyethylene. In a specific embodiment the fiber is poly(p-phenylene terephthalamide). In another specific embodiment, the fiber is polyethylene terephthalate. In a further specific embodiment, the fiber is alumina.
- In a more specific embodiment, the fiber is alpha alumina.
- An alternative bone fixation device has been invented. The alternative device comprises an absorbable polymer and a reinforcement material manufactured from a plurality of ultra high modulus polyethylene fibers. The absorbable polymer is obtained from the polymerization of dl-lactide.
- Another alternative bone fixation device has been invented. The device comprises an absorbable polymer, said polymer obtained from the copolymerization of 1-lactide, dl-lactide, and a monomer selected from the group consisting of glycolide, 1, 3-dioxan-2-one, and p-dioxanone and a reinforcement material. In one embodiment, the monomer is glycolide. In another embodiment, the monomer is 1,3-dioxan--2-one.
- In yet another embodiment, and in combination with any of the above alternative bone fixation device embodiments, the reinforcement material is a filler. In a specific embodiment, the filler is in particulate form. In a more specific embodiment, the particulate fiber is hydroxyapatite. In another specific embodiment, the filler is selected from the group consisting of tricalcium phosphate, hydroxyapatite, and a mixture thereof.
- In a still further embodiment, and in combination with any of the above (alternative device) polymer embodiments, the reinforcement material is manufactured from a plurality of fibers selected from the group consisting of alumina, poly(p-phenylene terephthalamide), polyethylene terephthalate, and ultra high modulus polyethylene. In a specific embodiment, the fiber is alumina. In a more specific embodiment, the fiber is alpha alumina.
- A laminated bone fixation device has also been invented. The device comprises an impregnating agent consisting of an absorbable polymer matrix. The polymer is obtained from the polymerization of 1-lactide. The matrix has an inherent viscosity of about 1.5 to 3.5 dl/g (0.5 g/dl in CHC13). The device also comprises a nonabsorbable reinforcement material. The reinforcement material consists essentially of at least one alumina fiber. The device has a flexural strength of about 10,000 to 25,000 psi; a flexural modulus of about IX106 to 5x106 psi; a loss of about 30% of initial flexural strength during 3 months in vivo and 60% during 6 months in vivo; and a loss of about 25% of initial flexural modulus during 3 months in vivo and 45% during 6 months in vivo.
- In one embodiment, the reinforcement material is a plurality of alpha alumina fibers. In a specific embodiment, the reinforcement material comprises about 10 to 60 volume percent of said fibers. In a more specific embodiment, the device comprises about 15 to 40 percent of said fibers. In another embodiment, the device has a flexural strength of about 15,000 to 25,000 psi. In a further embodiment, the device has a flexural modulus of up to about 3x106 psi.
-
- Figure 1 is a graph showing the in vivo flexural modulus degradation of the device of this invention, as contrasted with the moduli of prior art bone fixation devices;
- Figures 2 and 3 are graphs, similar to that of Figure 1, showing in vivo flexural strength and molecular weight degradation, respectively;
- Figure 4 is a top view of a bone fixation device manufactured from the composite materials of this invention;
- Figure 5 is a partially broken side view of Figure 4;
- Figure 6 is a front view of Figure 5; and
- Figure 7 is a broken perspective view of Figures 4 to 6 showing the use of the device on a mammalian bone.
- The following is a description for making the composite materials used in the bone fixation device of this invention.
-
- A) A monomer or monomer mixture is polymerized in bulk in a stirred reactor under nitrogen or vacuum. When the polymer melt viscosity reaches a maximum the particulate filler is added slowly to the concentration desired.
- B) A bioabsorbable matrix polymer is heated to melting under nitrogen or vacuum in a mixing chamber. To the melt, the particulate filler (tricalcium phosphate or hydroxyapatite) is added slowly until thorough mixing is observed at the desired concentration.
-
- A) Solution Impregnation and Laminations: The fiber or woven fabric is immersed in a solution of the biodegradable polymer in a low boiling point solvent (e.g. methylene chloride). The amount of polymer deposited on the fabric, chopped fiber or fiber yarn is dependent on the solution concentration, the polymer molecular weight (which effects solution viscosity) , the length of immersion time and the number of immersions. The impregnated chopped fiber, yarn or fabric (prepreg) is then thoroughly dried. The prepreg is laid-up in a mold of a predetermined thickness. Vacuum is applied to the lay-up by use of a vacuum bag. Heat and compression are then applied to consolidate the laminate.
- B) Melt Impregnation and Lamination: Films of the biodegradable polymer are made by solvent casting or melt pressing. Alternatively, fibrous mats are made from polymer by running a solution of the polymer into a non-solvent in a thin stream to form a stringy precipitate, followed by pressing into a mat at room temperature. The films or mats are then laid between yarn or fabric layers in a mold of a predetermined thickness. Vacuum is applied to the lay-up, by vacuum-bagging the mold, and heat and compression are applied to consolidate the laminate.
- Figures 4 to 6 show the bone fixation device. The device can be manufactured without undue experimentation by methods known in the prior art, e.g. by compression molding. The device can be attached to a bone by any means presently known or obvious to a person having ordinary skill in the art, for example by fastening with screws, staples and the like, or by bonding, for example, by gluing the device to the bone.
- Figures 4 to 6
show holes 2 which are used to each accommodate a screw 5 (shown in Figure 7). To accommodate the screw head, a plurality ofholes 2 are countersunk 3 in thedevice 1. - Referring specifically to Figures 4 and 5, four
holes 2 are shown. It is to be understood that any number of holes can be used, provided thedevice 1 is adequately attached to a bone 4 (shown in Figure 7). However, as a minimum, at least twoholes 2 andscrews 5 appear to be necessary. - Referring to Figure 7, the preferred relationship of the
device 1 to a mammalian bone 4 fracture is shown. Under many circumstances, the configuration shown in Figure 7 will allow the best possible chance for uniform healing of the fracture in the bone 4. - The following examples more fully describe the above embodiments.
- Poly(1-lactide)-Alumina Fiber Laminate: The laminate was formed from poly(l-lactide) of inherent viscosity 2.68 dl/g (0.5 g/dl in CHC13, after consolidation) and a fabric made from alumina fiber. Poly(l-lactide) was melt pressed into 4" by 4" square films, two films of 0.005" and two films of 0.023" thickness. The laminate was formed by stacking the films and fabric in alternating layers. Three plies of fabric were used. The 0.005" thick films were used for the -two outside layers. The laminate was consolidated by heating to 2000C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 19% alumina fabric by volume. The laminate had the following mechanical properties:
- This material is of particular interest due to it's superior in vivo performance in subcutaneous rabbit implant experiments. The degradation of this material in vivo is shown in Figures 1-3. Figures 1 and 2 show the physical property degradation profile and Figure 3 shows the molecular weight degradation profile, as contrasted with materials used in prior art bone fixation devices. The initial properties of this composite system can be varied over a wide range by varying fiber loading. In addition, the degradation profile can be altered by varying the initial molecular weight of the matrix polymer.
- Mechanical properties declined in a roughly linear manner over a 6 month period in rabbits to a level at 39% of initial flexural strength and 53% of initial flexural modulus. Inherent viscosity data suggest that mass loss of the poly(l-lactide) matrix would begin after approximately 42 weeks. After mass loss onset, the rate of mechanical property degradation should increase and any remaining load bearing capability would quickly deteriorate.
- Poly(1-lactide)-Kevlar Laminate: A laminate was formed which consisted of a poly(l-lactide) of inherent viscosity 1.00 dl/g (0.5 g/dl in CHCl3, before consolidation) and a satin weave Kevlar 49 fabric. The polymer was dissolved in methylene chloride at a concentration of 5% (w/v). Kevlar fabric was immersed in the solution to form a prepreg of 22% poly(l-lactide) by weight. Poly(l-lactide) was melt pressed into films approximately 0.004" thick. Seven polymer films and six plies of prepreg were laid-up in alternating layers. The laminate was consolidated by heating at 200°C in a vacuum bag and compressing to a thickness of 1/16". The resulting laminate was 49% Kevlar by volume. The laminate had the following mechanical properties:
- Poly(1-lactide)-Alumina Laminate: A laminate was formed which consisted of a poly(1-lactide) of inherent viscosity 1.64 dl/g (0.5 g/dl in CHC13, after consolidation) and a fabric made from alumina fiber. Poly(1-lactide) was reprecipitated from a chloroform solution into methanol. The dried precipitate was pressed into 4" by 4" square mats, two mats of 6.5 g and two mats of 1.2 g. The laminate was formed by stacking the mats and fabric in alternating layers. Three plies of fabric were used. The 1.2 g mats were used for the two outside layers. The laminate was consolidated by heating to 195°C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 17% alumina fabric by volume. The laminate had the following mechanical properties:
- Poly(1-lactidey-Alumina Laminate: A laminate was formed which consisted of a poly(1-lactide) of inherent viscosity 2.65 dl/g (0.5 g/dl in CHC13, after consolidation) and a fabric made from alumina fiber. Poly(1-lactide) was reprecipitated from a chloroform solution into methanol. The dried precipitate was pressed into 4" by 4" square mats, two mats of 6.5 g and two mats of 1.2 g. The laminate was formed by stacking the mats and fabric in alternating layers. Three plies of fabric were used. The 1.2 g mats were used for the two outside layers. The laminate was consolidated by heating to 195°C in a vacuum bag and compressing to a-thickness of 1/16". The laminate contained 17% alumina fabric by volume. The laminate had the following mechanical properties:
- Poly(1-lactide)-Alumina Laminate: A laminate was formed which consisted of a poly(l-lactide) of inherent viscosity 4.14 dl/g (0.5 g/dl in CHC13, after consolidation) and a fabric made from alumina fiber. Poly(l-lactide) was reprecipitated from a chloroform solution into methanol. The dried precipitate was pressed into 4" by 4" square mats, two mats of 6.5 g and two mats of 1.2 g. The laminate was formed by stacking the mats and fabric in alternating layers. Three plies of fabric were used. The 1.2 g mats were used for the two outside layers. The laminate was consolidated by heating to 1950C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 17% alumina fabric by volume. The laminate had the following mechanical properties:
-
- Poly(1-lactide)-Alumina Laminate: A laminate was formed which consisted of a poly(l-lactide) of inherent viscosity 2.64 dl/g (0.5 g/dl in CHC13, before consolidation) and a fabric made from alumina fiber. Poly(l-lactide) was melt pressed into 4" by 4" square films, two films of 0.005" and one film of 0.045" thickness. The laminate was formed by stacking the films and fabric in alternating layers. Two plies of fabric were used. The 0.005" films were used for the two outside layers. The laminate was consolidated by heating to 200°C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 13% alumina fabric by volume. The laminate had the following mechanical properties:
- Poly(1-lactide)-Alumina Laminate: A laminate was formed which consisted of a poly(l-lactide) of inherent viscosity 2.64 dl/g (0.5 g/dl in CHC13, before consolidation) and a fabric made from alumina fiber. Poly(l-lactide) was melt pressed into 4" by 4" square films, two films of 0.005" and two films of 0.023" thickness. The laminate was formed by stacking the films and fabric in alternating layers. Three plies of fabric were used. The 0.005" films were used for the two outside layers. The laminate was consolidated by heating to 200°C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 19% alumina fabric by volume. The laminate had the following mechanical properties:
- Poly(1-lactide)-Alumina Laminate: A laminate was formed which consisted of a poly(l-lactide) of inherent viscosity 2.64 dl/g (0.5 g/dl in CHC13, before consolidation) and a fabric made from alumina fiber. Poly(1-lactide) was melt pressed into 4" by 4" square films, two films of 0.005" and three films of 0.015" thickness. The laminate was formed by stacking the films and fabric in alternating layers. Four plies of fabric were used. The 0.005" films were used for the two outside layers. The laminate was consolidated by heating to 200°C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 24% alumina fabric by volume. The laminate had the following mechanical properties:
- Poly(1-lactide)-Alumina Laminate: A laminate was formed which consisted of a poly(l-lactide) of inherent viscosity 2.64 dl/g (0.5 g/dl in CHCl3, before consolidation) and a fabric made from alumina fiber. Poly(l-lactide) was melt pressed into 4" by 4" square films, two films of 0.005" a.nd four films of 0.008" thickness. The laminate was formed by stacking the films and fabric in alternating layers. Five plies of fabric were used. The 0.005" films were used for the two outside layers. The laminate was consolidated by heating to 200°C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 30% alumina fabric by volume. The laminate had the following mechanical properties:
-
- Poly(1-lactide)-Alumina Laminate: A laminate was formed by impregnating 1/2" chopped alumina fiber with poly(l-lactide). The polymer had an inherent viscosity of 2.64 dl/g (0.5 g/dl in CHC13, before consolidation). The impregnation was accomplished by dissolving the polymer in chloroform (10 g/dl) followed by stirring in the chopped fiber. The mixture was then dried under vacuum to constant weight. The impregnated fiber was consolidated using vacuum and compression at 200°C, forming a laminate containing 30% alumina by volume. The laminate had the following mechanical properties:
- In Vitro Degradation of Poly(l-lactide)-Alumina Laminates: An accelerated in vitro degradation test was used to assess the relative degradation rates of laminates made with poly(1-lactide)s of different molecular weights reinforced with alumina fabric. The in vitro procedure involved immersing the sample in a pH 6.09 phosphate buffered aqueous solution at 67°C. The samples were removed from the bath, dried and tested for mechanical properties using the ASTM D790 method. Samples from Examples 3, 4 and 5 were used in this study. The results are shown in Table I. These data indicate that the composite fabricated with the lower molecular weight polymer (Example 3) possessed higher initial mechanical properties than the composites made with higher molecular weight polymers. It also appeared to have less scatter in its degradation profile.
- In Vitro Degradation of Poly(1-lactide)-Alumina Laminates: An accelerated in vitro degradation test was used to assess the relative degradation rates of laminates made with poly(l-lactide) reinforced with different loadings of alumina fabric. The in vitro procedure was identical to that described in Example 11. Samples from Examples 6, 7, 8 and 9 were used in this study. The results are shown in Table II. These data indicate that the composites possessed higher initial mechanical properties as the fabric volume increased. This relationship allows the tailoring of a material to have the mechanical properties desirable for a specific application within a fairly broad range.
- Poly(dl-lactide)-Polyethylene Laminate: A laminate was constructed using Ultra High Modulus Polyethylene (UHMPE) and poly(dl-lactide). The UHMPE fiber was laid-up in unidirectional plies with 0°, 90° orientation. Between each ply, a 0.003" thick film (melt pressed) of poly(dl-lactide) was laid. A film of polymer was placed on the top and the bottom of the lay-up as well. The laminate was consolidated by heating to 120°C in a vacuum bag and compressing to a thickness of 1/16". The laminate contained 41% UHMPE by volume. The laminate had the following mechanical properties:
-
- Poly(1-lactide)-Polyethylene Terephthalate Laminate: Poly(l-lactide) with an initial inherent viscosity of 3.63 dl/g (0.5 g/dl in CHC13) was dissolved in CHC13/ethyl acetate (V/V 9/1), at a concentration of 10% (w/v). Polyethylene terephthalate fabric was impregnated by dipping in the solution to a coating level of~50% by weight. Six plies of this prepreg were then consolidated in a heated hydraulic press at 180*C for 3 minutes with about 1500 psi pressure. The resulting laminate had a flexural modulus of 0.43 X 106 psi.
- Poly(l-lactide)-Hydroxyapatite Composite: Poly-(1-lactide) was prepared by charging 100 g of 1-lactide, 15.5 ul (0.01 mole %) lauryl alcohol and 15.6 mg (0.01 mole %) stannous chloride dihydrate into a stirred reactor at 200°C. When the power drain on the stirring motor reached a maximum, 45 g of hydroxyapatite (Ca10(OH)2(PO4)6, Mallinckrodt) was added. The composite was discharged after it appeared homogeneous (about 5 min.). The composite contained about 14% hydroxyapatite by volume. The flexural properties of a compression molded plaque were:
Claims (10)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US900957 | 1986-08-27 | ||
US06/900,957 US4781183A (en) | 1986-08-27 | 1986-08-27 | Surgical prosthesis |
Publications (3)
Publication Number | Publication Date |
---|---|
EP0258692A2 true EP0258692A2 (en) | 1988-03-09 |
EP0258692A3 EP0258692A3 (en) | 1990-04-04 |
EP0258692B1 EP0258692B1 (en) | 1994-06-15 |
Family
ID=25413362
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP87111585A Expired - Lifetime EP0258692B1 (en) | 1986-08-27 | 1987-08-11 | Surgical prothesis |
Country Status (13)
Country | Link |
---|---|
US (1) | US4781183A (en) |
EP (1) | EP0258692B1 (en) |
JP (1) | JPS6389166A (en) |
KR (1) | KR950008174B1 (en) |
AU (1) | AU599413B2 (en) |
CA (1) | CA1263791A (en) |
DE (1) | DE3750061T2 (en) |
DK (1) | DK169278B1 (en) |
ES (1) | ES2054634T3 (en) |
FI (1) | FI873700A (en) |
IL (1) | IL83538A (en) |
NO (1) | NO172169C (en) |
ZA (1) | ZA876366B (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0352972A2 (en) * | 1988-07-29 | 1990-01-31 | BAXTER INTERNATIONAL INC. (a Delaware corporation) | Fiber-reinforced expanded fluoroplastic vascular grafts |
DE3831657A1 (en) * | 1988-09-17 | 1990-03-22 | Boehringer Ingelheim Kg | DEVICE FOR THE OSTEOSYNTHESIS AND METHOD FOR THE PRODUCTION THEREOF |
GR880100802A (en) * | 1988-11-28 | 1990-12-31 | Petros Koutsoukos | Deposition of xydroxyapatite on modified polymers |
DE4243913A1 (en) * | 1991-12-25 | 1993-07-01 | Gunze Kk | Pins for holding fractured bones together whilst the fracture is healing - are made from biologically degradable polymer and do not need to be removed after the fracture has healed |
DE19805673A1 (en) * | 1998-02-12 | 1999-08-26 | Quante | Production of injectable bone replacement and augmentation material that hardens at site of application |
Families Citing this family (123)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6368155A (en) * | 1986-09-11 | 1988-03-28 | グンゼ株式会社 | Bone bonding pin |
FI81498C (en) * | 1987-01-13 | 1990-11-12 | Biocon Oy | SURGICAL MATERIAL OCH INSTRUMENT. |
US4966599A (en) * | 1987-04-07 | 1990-10-30 | Pollock Richard A | Anatomical precontoured plating, instruments and methods |
BR8707937A (en) * | 1987-11-03 | 1990-02-13 | Synthes Ag | PROSTHESIS FOR OSTEOSYNTHESIS |
CH673762A5 (en) * | 1987-12-02 | 1990-04-12 | Synthes Ag | |
DE3841288A1 (en) * | 1988-12-08 | 1990-06-13 | Pertti Prof Dr Toermaelae | OSTEOSYNTHESE IMPLANTS |
US5290494A (en) * | 1990-03-05 | 1994-03-01 | Board Of Regents, The University Of Texas System | Process of making a resorbable implantation device |
US5080665A (en) * | 1990-07-06 | 1992-01-14 | American Cyanamid Company | Deformable, absorbable surgical device |
CA2060635A1 (en) * | 1991-02-12 | 1992-08-13 | Keith D'alessio | Bioabsorbable medical implants |
EP0523926A3 (en) * | 1991-07-15 | 1993-12-01 | Smith & Nephew Richards Inc | Prosthetic implants with bioabsorbable coating |
US5391768A (en) * | 1993-03-25 | 1995-02-21 | United States Surgical Corporation | Purification of 1,4-dioxan-2-one by crystallization |
US5721049A (en) * | 1993-11-15 | 1998-02-24 | Trustees Of The University Of Pennsylvania | Composite materials using bone bioactive glass and ceramic fibers |
US6121172A (en) * | 1993-11-15 | 2000-09-19 | The Trustees Of The University Of Pennsylvania | Composite materials using bone bioactive glass and ceramic fibers |
US5468544A (en) * | 1993-11-15 | 1995-11-21 | The Trustees Of The University Of Pennsylvania | Composite materials using bone bioactive glass and ceramic fibers |
US5569250A (en) * | 1994-03-01 | 1996-10-29 | Sarver; David R. | Method and apparatus for securing adjacent bone portions |
US20020169485A1 (en) | 1995-10-16 | 2002-11-14 | Neuropace, Inc. | Differential neurostimulation therapy driven by physiological context |
US6944501B1 (en) * | 2000-04-05 | 2005-09-13 | Neurospace, Inc. | Neurostimulator involving stimulation strategies and process for using it |
US6696499B1 (en) * | 1996-07-11 | 2004-02-24 | Life Medical Sciences, Inc. | Methods and compositions for reducing or eliminating post-surgical adhesion formation |
US5711958A (en) * | 1996-07-11 | 1998-01-27 | Life Medical Sciences, Inc. | Methods for reducing or eliminating post-surgical adhesion formation |
ZA978537B (en) | 1996-09-23 | 1998-05-12 | Focal Inc | Polymerizable biodegradable polymers including carbonate or dioxanone linkages. |
FI105159B (en) * | 1996-10-25 | 2000-06-30 | Biocon Ltd | Surgical implant, agent or part thereof |
JP3426460B2 (en) * | 1996-10-25 | 2003-07-14 | グンゼ株式会社 | Osteosynthesis |
JP3718306B2 (en) * | 1997-01-06 | 2005-11-24 | 経憲 武井 | Artificial acetabulum and hip joint |
ATE395001T1 (en) | 1997-02-11 | 2008-05-15 | Warsaw Orthopedic Inc | PLATE FOR THE FRONT CERVICAL SPINE WITH FIXATION SYSTEM FOR ONE SCREW |
AU6145998A (en) | 1997-02-11 | 1998-08-26 | Gary Karlin Michelson | Skeletal plating system |
US6211249B1 (en) | 1997-07-11 | 2001-04-03 | Life Medical Sciences, Inc. | Polyester polyether block copolymers |
US5935127A (en) * | 1997-12-17 | 1999-08-10 | Biomet, Inc. | Apparatus and method for treatment of a fracture in a long bone |
JPH11206871A (en) * | 1998-01-27 | 1999-08-03 | Bmg:Kk | In vivo degradable and absorptive bone fixing material and its manufacture |
US5938664A (en) * | 1998-03-31 | 1999-08-17 | Zimmer, Inc. | Orthopaedic bone plate |
US6206883B1 (en) | 1999-03-05 | 2001-03-27 | Stryker Technologies Corporation | Bioabsorbable materials and medical devices made therefrom |
CA2367085C (en) * | 1999-03-09 | 2007-08-07 | Synthes (U.S.A.) | Bone plate with partly-threaded elongated hole |
US6783529B2 (en) | 1999-04-09 | 2004-08-31 | Depuy Orthopaedics, Inc. | Non-metal inserts for bone support assembly |
US6296645B1 (en) | 1999-04-09 | 2001-10-02 | Depuy Orthopaedics, Inc. | Intramedullary nail with non-metal spacers |
DE19936133C2 (en) * | 1999-07-31 | 2002-11-21 | Aesculap Ag & Co Kg | Plastic bone plate |
US6473639B1 (en) | 2000-03-02 | 2002-10-29 | Neuropace, Inc. | Neurological event detection procedure using processed display channel based algorithms and devices incorporating these procedures |
US6466822B1 (en) | 2000-04-05 | 2002-10-15 | Neuropace, Inc. | Multimodal neurostimulator and process of using it |
US6395033B1 (en) * | 2000-04-10 | 2002-05-28 | Tyco Healthcare Group Lp | Dynamic fusion mechanostat devices |
US6605090B1 (en) * | 2000-10-25 | 2003-08-12 | Sdgi Holdings, Inc. | Non-metallic implant devices and intra-operative methods for assembly and fixation |
US6529774B1 (en) | 2000-11-09 | 2003-03-04 | Neuropace, Inc. | Extradural leads, neurostimulator assemblies, and processes of using them for somatosensory and brain stimulation |
US7005135B2 (en) * | 2001-01-30 | 2006-02-28 | Ethicon Inc. | Glass scaffolds with controlled resorption rates and methods for making same |
KR100383433B1 (en) * | 2001-06-29 | 2003-05-12 | 주식회사 씨엠리서치 | Method for preparing bioabsorbable organic/inorganic composition for bone fixation devices and itself prepared thereby |
US6747121B2 (en) | 2001-09-05 | 2004-06-08 | Synthes (Usa) | Poly(L-lactide-co-glycolide) copolymers, methods for making and using same, and devices containing same |
US7682392B2 (en) | 2002-10-30 | 2010-03-23 | Depuy Spine, Inc. | Regenerative implants for stabilizing the spine and devices for attachment of said implants |
US7951176B2 (en) | 2003-05-30 | 2011-05-31 | Synthes Usa, Llc | Bone plate |
ES2348987T3 (en) | 2003-08-26 | 2010-12-21 | Synthes Gmbh | BONE PLATE. |
US11259851B2 (en) | 2003-08-26 | 2022-03-01 | DePuy Synthes Products, Inc. | Bone plate |
AU2003257355B2 (en) | 2003-09-08 | 2008-05-29 | Synthes Gmbh | Bone fixing device |
US8016865B2 (en) * | 2003-09-29 | 2011-09-13 | Depuy Mitek, Inc. | Method of performing anterior cruciate ligament reconstruction using biodegradable interference screw |
US7699879B2 (en) * | 2003-10-21 | 2010-04-20 | Warsaw Orthopedic, Inc. | Apparatus and method for providing dynamizable translations to orthopedic implants |
US20050085814A1 (en) * | 2003-10-21 | 2005-04-21 | Sherman Michael C. | Dynamizable orthopedic implants and their use in treating bone defects |
WO2005041796A1 (en) * | 2003-10-30 | 2005-05-12 | Synthes Gmbh | Bone plate |
ATE540628T1 (en) | 2003-12-01 | 2012-01-15 | Smith & Nephew Inc | HUMERAL NAIL WITH INSERT FOR FIXING A SCREW |
US20050136764A1 (en) * | 2003-12-18 | 2005-06-23 | Sherman Michael C. | Designed composite degradation for spinal implants |
US8574268B2 (en) | 2004-01-26 | 2013-11-05 | DePuy Synthes Product, LLC | Highly-versatile variable-angle bone plate system |
US11291484B2 (en) | 2004-01-26 | 2022-04-05 | DePuy Synthes Products, Inc. | Highly-versatile variable-angle bone plate system |
US7637928B2 (en) | 2004-01-26 | 2009-12-29 | Synthes Usa, Llc | Variable angle locked bone fixation system |
US20060173458A1 (en) * | 2004-10-07 | 2006-08-03 | Micah Forstein | Bone fracture fixation system |
US8545866B2 (en) | 2004-10-29 | 2013-10-01 | Smith & Nephew, Inc. | Bioabsorbable polymers |
DE602005013262D1 (en) * | 2004-10-29 | 2009-04-23 | Smith & Nephew Inc | BIOABSORBABLE POLYMERS WITH CALCIUM CARBONATE |
US8394130B2 (en) | 2005-03-17 | 2013-03-12 | Biomet C.V. | Modular fracture fixation system |
US8062296B2 (en) * | 2005-03-17 | 2011-11-22 | Depuy Products, Inc. | Modular fracture fixation plate system with multiple metaphyseal and diaphyseal plates |
US7410488B2 (en) | 2005-02-18 | 2008-08-12 | Smith & Nephew, Inc. | Hindfoot nail |
US7727278B2 (en) * | 2005-03-04 | 2010-06-01 | Rti Biologics, Inc. | Self fixing assembled bone-tendon-bone graft |
US7763071B2 (en) * | 2005-03-04 | 2010-07-27 | Rti Biologics, Inc. | Bone block assemblies and their use in assembled bone-tendon-bone grafts |
US7763072B2 (en) * | 2005-03-04 | 2010-07-27 | Rti Biologics, Inc. | Intermediate bone block and its use in bone block assemblies and assembled bone-tendon-bone grafts |
US8470038B2 (en) | 2005-03-04 | 2013-06-25 | Rti Biologics, Inc. | Adjustable and fixed assembled bone-tendon-bone graft |
US20060247638A1 (en) * | 2005-04-29 | 2006-11-02 | Sdgi Holdings, Inc. | Composite spinal fixation systems |
US20070118128A1 (en) * | 2005-11-22 | 2007-05-24 | Depuy Spine, Inc. | Implant fixation methods and apparatus |
US20070118130A1 (en) * | 2005-11-22 | 2007-05-24 | Depuy Spine, Inc. | Implant fixation methods and apparatus |
US20070118129A1 (en) * | 2005-11-22 | 2007-05-24 | Depuy Spine, Inc. | Implant fixation methods and apparatus |
US20070118127A1 (en) * | 2005-11-22 | 2007-05-24 | Depuy Spine, Inc. | Implant fixation methods and apparatus |
US20070154514A1 (en) * | 2005-12-30 | 2007-07-05 | Demakas John J | Therapeutic Structures |
US7867261B2 (en) * | 2006-03-17 | 2011-01-11 | Depuy Products, Inc. | Bone plate with variable torsional stiffness at fixed angle holes |
US8221468B2 (en) * | 2006-05-11 | 2012-07-17 | Gaines Jr Robert W | Use of bioabsorbable materials for anterior extradiscal correction of thoracolumbar pathologies |
US7923020B2 (en) * | 2006-09-29 | 2011-04-12 | Depuy Products, Inc. | Composite for implantation in the body of an animal and method for making the same |
EP2131750B1 (en) * | 2007-03-06 | 2016-05-04 | Covidien LP | Wound closure material |
US20100076489A1 (en) * | 2007-03-06 | 2010-03-25 | Joshua Stopek | Wound closure material |
JP5034786B2 (en) * | 2007-08-30 | 2012-09-26 | 東レ株式会社 | Easy degradable film |
JP5330392B2 (en) | 2007-09-18 | 2013-10-30 | ストライカー トラウマ ゲーエムベーハー | Stable fixation system by implant angle |
US20090138092A1 (en) * | 2007-11-28 | 2009-05-28 | Johnston Brent W | Therapeutic Structures for Utilization in Temporomandibular Joint Replacement Systems |
US8100949B2 (en) * | 2008-06-03 | 2012-01-24 | Warsaw Orthopedic, Inc. | Transverse rod connectors with osteoconductive material |
US9642658B2 (en) * | 2008-10-15 | 2017-05-09 | Orthoclip Llc | Device and method for delivery of therapeutic agents via internal implants |
US20100130959A1 (en) * | 2008-10-15 | 2010-05-27 | Palmetto Biomedical, Inc. | Device and method for delivery of therapeutic agents via artificial internal implants |
CN102497830A (en) | 2009-09-14 | 2012-06-13 | 斯恩蒂斯有限公司 | Variable angle compression plate |
US9011494B2 (en) | 2009-09-24 | 2015-04-21 | Warsaw Orthopedic, Inc. | Composite vertebral rod system and methods of use |
US8709092B2 (en) | 2011-02-16 | 2014-04-29 | Genesis Medical Devices, LLC | Periprosthetic fracture management enhancements |
JP6502161B2 (en) * | 2015-05-11 | 2019-04-17 | 帝人メディカルテクノロジー株式会社 | Bone cement |
US10687874B2 (en) | 2015-08-27 | 2020-06-23 | Globus Medical, Inc | Proximal humeral stabilization system |
US11076898B2 (en) | 2015-08-27 | 2021-08-03 | Globus Medical, Inc. | Proximal humeral stabilization system |
US11197682B2 (en) | 2015-08-27 | 2021-12-14 | Globus Medical, Inc. | Proximal humeral stabilization system |
US10130402B2 (en) | 2015-09-25 | 2018-11-20 | Globus Medical, Inc. | Bone fixation devices having a locking feature |
US9974581B2 (en) | 2015-11-20 | 2018-05-22 | Globus Medical, Inc. | Expandable intramedullary systems and methods of using the same |
US9795411B2 (en) | 2016-03-02 | 2017-10-24 | Globus Medical, Inc. | Fixators for bone stabilization and associated systems and methods |
US10531905B2 (en) | 2016-04-19 | 2020-01-14 | Globus Medical, Inc. | Implantable compression screws |
US10751098B2 (en) | 2016-08-17 | 2020-08-25 | Globus Medical Inc. | Stabilization systems |
US11432857B2 (en) | 2016-08-17 | 2022-09-06 | Globus Medical, Inc. | Stabilization systems |
US10420596B2 (en) | 2016-08-17 | 2019-09-24 | Globus Medical, Inc. | Volar distal radius stabilization system |
US11331128B2 (en) | 2016-08-17 | 2022-05-17 | Globus Medical Inc. | Distal radius stabilization system |
US11197701B2 (en) | 2016-08-17 | 2021-12-14 | Globus Medical, Inc. | Stabilization systems |
US10575884B2 (en) | 2016-08-17 | 2020-03-03 | Globus Medical, Inc. | Fracture plates, systems, and methods |
US10383668B2 (en) | 2016-08-17 | 2019-08-20 | Globus Medical, Inc. | Volar distal radius stabilization system |
US11141204B2 (en) | 2016-08-17 | 2021-10-12 | Globus Medical Inc. | Wrist stabilization systems |
US11213327B2 (en) | 2016-08-17 | 2022-01-04 | Globus Medical, Inc. | Fracture plates, systems, and methods |
US10687873B2 (en) | 2016-08-17 | 2020-06-23 | Globus Medical Inc. | Stabilization systems |
US10905476B2 (en) | 2016-09-08 | 2021-02-02 | DePuy Synthes Products, Inc. | Variable angle bone plate |
US10624686B2 (en) | 2016-09-08 | 2020-04-21 | DePuy Synthes Products, Inc. | Variable angel bone plate |
US10820930B2 (en) | 2016-09-08 | 2020-11-03 | DePuy Synthes Products, Inc. | Variable angle bone plate |
US10881438B2 (en) | 2017-03-10 | 2021-01-05 | Globus Medical, Inc. | Clavicle fixation system |
US10905477B2 (en) | 2017-03-13 | 2021-02-02 | Globus Medical, Inc. | Bone stabilization systems |
US10368928B2 (en) | 2017-03-13 | 2019-08-06 | Globus Medical, Inc. | Bone stabilization systems |
US10856920B2 (en) | 2017-09-13 | 2020-12-08 | Globus Medical Inc. | Bone stabilization systems |
US11096730B2 (en) | 2017-09-13 | 2021-08-24 | Globus Medical Inc. | Bone stabilization systems |
JP6842170B2 (en) * | 2017-09-28 | 2021-03-17 | 国立大学法人 岡山大学 | Manufacturing method of biological tissue adhesive and biological tissue adhesive |
US11224468B2 (en) | 2018-03-02 | 2022-01-18 | Globus Medical, Inc. | Distal tibial plating system |
US11071570B2 (en) | 2018-03-02 | 2021-07-27 | Globus Medical, Inc. | Distal tibial plating system |
US11026727B2 (en) | 2018-03-20 | 2021-06-08 | DePuy Synthes Products, Inc. | Bone plate with form-fitting variable-angle locking hole |
US10772665B2 (en) | 2018-03-29 | 2020-09-15 | DePuy Synthes Products, Inc. | Locking structures for affixing bone anchors to a bone plate, and related systems and methods |
US11141172B2 (en) | 2018-04-11 | 2021-10-12 | Globus Medical, Inc. | Method and apparatus for locking a drill guide in a polyaxial hole |
US11013541B2 (en) | 2018-04-30 | 2021-05-25 | DePuy Synthes Products, Inc. | Threaded locking structures for affixing bone anchors to a bone plate, and related systems and methods |
US10925651B2 (en) | 2018-12-21 | 2021-02-23 | DePuy Synthes Products, Inc. | Implant having locking holes with collection cavity for shavings |
US11202663B2 (en) | 2019-02-13 | 2021-12-21 | Globus Medical, Inc. | Proximal humeral stabilization systems and methods thereof |
US11129627B2 (en) | 2019-10-30 | 2021-09-28 | Globus Medical, Inc. | Method and apparatus for inserting a bone plate |
US11723647B2 (en) | 2019-12-17 | 2023-08-15 | Globus Medical, Inc. | Syndesmosis fixation assembly |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2364644A1 (en) * | 1976-09-20 | 1978-04-14 | Inst Nat Sante Rech Med | NEW MATERIAL FOR BONE PROSTHESIS AND ITS APPLICATION |
EP0011528B1 (en) * | 1978-10-20 | 1985-02-20 | Centre National De La Recherche Scientifique (Cnrs) | Osteosynthesis elements and their preparation |
EP0146398A2 (en) * | 1983-12-19 | 1985-06-26 | Southern Research Institute | Method of producing biodegradable prothesis and products therefrom |
WO1986000533A1 (en) * | 1984-07-10 | 1986-01-30 | Rijksuniversiteit Te Groningen | Bone implant |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR11528E (en) * | 1908-09-29 | 1910-03-05 | Maurice Baudou | Puncture-proof and puncture-proof pneumatic tire for the wheels of all vehicles |
DE2546824C2 (en) * | 1975-10-18 | 1986-05-07 | Ernst Leitz Wetzlar Gmbh, 6330 Wetzlar | Coated endoprosthesis and process for their manufacture |
US4512038A (en) * | 1979-04-27 | 1985-04-23 | University Of Medicine And Dentistry Of New Jersey | Bio-absorbable composite tissue scaffold |
US4338926A (en) * | 1980-11-21 | 1982-07-13 | Howmedica, Inc. | Bone fracture prosthesis with controlled stiffness |
DK154260C (en) * | 1981-02-20 | 1989-05-22 | Mundipharma Gmbh | PROCEDURE FOR THE MANUFACTURING OF A BONE IMPLANT OF FURNISHED TRICAL CUMPHOSPHATE, SPECIFICALLY FOR FILLING OF SPACES OR FOR COMPOSITION OF BONE PARTS AFTER FRACTURE. |
US4550449A (en) * | 1982-11-08 | 1985-11-05 | Johnson & Johnson Products Inc. | Absorbable bone fixation device |
ES526645A0 (en) * | 1982-12-02 | 1985-09-01 | Wallone Region | IMPROVEMENTS INTRODUCED IN THE PROCESS TO OBTAIN BIOREACTIVE MATERIALS |
US4636526A (en) * | 1985-02-19 | 1987-01-13 | The Dow Chemical Company | Composites of unsintered calcium phosphates and synthetic biodegradable polymers useful as hard tissue prosthetics |
-
1986
- 1986-08-27 US US06/900,957 patent/US4781183A/en not_active Expired - Lifetime
-
1987
- 1987-08-11 EP EP87111585A patent/EP0258692B1/en not_active Expired - Lifetime
- 1987-08-11 ES ES87111585T patent/ES2054634T3/en not_active Expired - Lifetime
- 1987-08-11 DE DE3750061T patent/DE3750061T2/en not_active Expired - Fee Related
- 1987-08-14 IL IL83538A patent/IL83538A/en not_active IP Right Cessation
- 1987-08-25 CA CA000545263A patent/CA1263791A/en not_active Expired
- 1987-08-26 FI FI873700A patent/FI873700A/en not_active Application Discontinuation
- 1987-08-26 AU AU77464/87A patent/AU599413B2/en not_active Ceased
- 1987-08-26 ZA ZA876366A patent/ZA876366B/en unknown
- 1987-08-26 KR KR1019870009363A patent/KR950008174B1/en not_active IP Right Cessation
- 1987-08-26 JP JP62210359A patent/JPS6389166A/en active Pending
- 1987-08-26 DK DK446187A patent/DK169278B1/en active
- 1987-08-26 NO NO873598A patent/NO172169C/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2364644A1 (en) * | 1976-09-20 | 1978-04-14 | Inst Nat Sante Rech Med | NEW MATERIAL FOR BONE PROSTHESIS AND ITS APPLICATION |
EP0011528B1 (en) * | 1978-10-20 | 1985-02-20 | Centre National De La Recherche Scientifique (Cnrs) | Osteosynthesis elements and their preparation |
EP0146398A2 (en) * | 1983-12-19 | 1985-06-26 | Southern Research Institute | Method of producing biodegradable prothesis and products therefrom |
WO1986000533A1 (en) * | 1984-07-10 | 1986-01-30 | Rijksuniversiteit Te Groningen | Bone implant |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0352972A2 (en) * | 1988-07-29 | 1990-01-31 | BAXTER INTERNATIONAL INC. (a Delaware corporation) | Fiber-reinforced expanded fluoroplastic vascular grafts |
EP0352972A3 (en) * | 1988-07-29 | 1991-01-02 | BAXTER INTERNATIONAL INC. (a Delaware corporation) | Fiber-reinforced expanded fluoroplastic vascular grafts |
DE3831657A1 (en) * | 1988-09-17 | 1990-03-22 | Boehringer Ingelheim Kg | DEVICE FOR THE OSTEOSYNTHESIS AND METHOD FOR THE PRODUCTION THEREOF |
GR880100802A (en) * | 1988-11-28 | 1990-12-31 | Petros Koutsoukos | Deposition of xydroxyapatite on modified polymers |
DE4243913A1 (en) * | 1991-12-25 | 1993-07-01 | Gunze Kk | Pins for holding fractured bones together whilst the fracture is healing - are made from biologically degradable polymer and do not need to be removed after the fracture has healed |
DE4243913C2 (en) * | 1991-12-25 | 2000-10-05 | Gunze Kk | Bone treatment devices and methods of making them |
DE19805673A1 (en) * | 1998-02-12 | 1999-08-26 | Quante | Production of injectable bone replacement and augmentation material that hardens at site of application |
DE19805673C2 (en) * | 1998-02-12 | 2002-09-26 | Wolfgang Quante | Process and kit for making bone replacement and augmentation material |
Also Published As
Publication number | Publication date |
---|---|
KR950008174B1 (en) | 1995-07-26 |
NO873598L (en) | 1988-02-29 |
JPS6389166A (en) | 1988-04-20 |
FI873700A0 (en) | 1987-08-26 |
FI873700A (en) | 1988-02-28 |
DK169278B1 (en) | 1994-10-03 |
ES2054634T3 (en) | 1994-08-16 |
DE3750061D1 (en) | 1994-07-21 |
DK446187A (en) | 1988-02-28 |
US4781183A (en) | 1988-11-01 |
NO172169B (en) | 1993-03-08 |
AU599413B2 (en) | 1990-07-19 |
DK446187D0 (en) | 1987-08-26 |
IL83538A (en) | 1992-03-29 |
EP0258692A3 (en) | 1990-04-04 |
AU7746487A (en) | 1988-03-03 |
KR880002496A (en) | 1988-05-09 |
EP0258692B1 (en) | 1994-06-15 |
DE3750061T2 (en) | 1995-01-26 |
NO873598D0 (en) | 1987-08-26 |
ZA876366B (en) | 1988-04-27 |
CA1263791A (en) | 1989-12-05 |
NO172169C (en) | 1993-06-16 |
IL83538A0 (en) | 1988-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0258692A2 (en) | Surgical prothesis | |
Matsusue et al. | In vitro and in vivo studies on bioabsorbable ultra‐high‐strength poly (l‐lactide) rods | |
Vainionpää et al. | Strength and strength retention vitro, of absorbable, self-reinforced polyglycolide (PGA) rods for fracture fixation | |
EP0460439B1 (en) | Deformable surgical device | |
Bos et al. | Bio-absorbable plates and screws for internal fixation of mandibular fractures: A study in six dogs | |
US4655777A (en) | Method of producing biodegradable prosthesis and products therefrom | |
US4743257A (en) | Material for osteosynthesis devices | |
US6147135A (en) | Fabrication of biocompatible polymeric composites | |
US7541049B1 (en) | Bioactive and biodegradable composites of polymers and ceramics or glasses and method to manufacture such composites | |
Agrawal et al. | Fabrication and characterization of PLA-PGA orthopedic implants | |
Zimmerman et al. | The design and analysis of a laminated partially degradable composite bone plate for fracture fixation | |
EP1874366A2 (en) | A bioabsorbable and bioactive composite material and a method for manufacturing the composite | |
FI83477B (en) | ABSORBER MATERIAL FOER FIXERING AV VAEVNADER. | |
Bleach et al. | Effect of filler type on the mechanical properties of self-reinforced polylactide–calcium phosphate composites | |
Deb et al. | Effect of crosslinking agents on acrylic bone cements based on poly (methylmethacrylate) | |
Dauner et al. | Resorbable continuous-fibre reinforced polymers for osteosynthesis | |
Hasirci et al. | High strength bioresorbable bone plates: preparation, mechanical properties and in vitro analysis | |
Fambri et al. | Characterization of modulus and glass transition phenomena in poly (L‐lactide)/hydroxyapatite composites | |
FI78238C (en) | SURGICAL PURPOSE SYNTHESIS. | |
Kellomäki et al. | Pliable polylactide plates for guided bone regeneration: manufacturing and in vitro | |
Eitenmuller et al. | New Semi-Rigid and Absorbable Osteosynthesis Devices with a High Molecular Weight Polylactide (An Experimental Investigation | |
Casper et al. | Biodegradable fracture fixation plates for use in maxillofacial surgery | |
Klein et al. | Filament-wound composite soft tissue prostheses: controlling compliance and strength by water absorption and degradation | |
Hedjazi | Assessment of processing techniques for Orthopaedic Composites | |
Kim et al. | Partially biodegradable bone cement for bone ingrowth (I): Preparation and physical properties |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): BE CH DE ES FR GB IT LI NL SE |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): BE CH DE ES FR GB IT LI NL SE |
|
17P | Request for examination filed |
Effective date: 19901004 |
|
17Q | First examination report despatched |
Effective date: 19910610 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: AMERICAN CYANAMID COMPANY |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): BE CH DE ES FR GB IT LI NL SE |
|
REF | Corresponds to: |
Ref document number: 3750061 Country of ref document: DE Date of ref document: 19940721 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2054634 Country of ref document: ES Kind code of ref document: T3 |
|
ET | Fr: translation filed | ||
ITF | It: translation for a ep patent filed |
Owner name: MODIANO & ASSOCIATI S.R.L. |
|
EAL | Se: european patent in force in sweden |
Ref document number: 87111585.3 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PUE Owner name: AMERICAN CYANAMID COMPANY TRANSFER- ACUFEX MICROSU Ref country code: CH Ref legal event code: NV Representative=s name: BOVARD AG PATENTANWAELTE |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 19960802 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 19960809 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 19960815 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 19960816 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 19960821 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 19960828 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 19960830 Year of fee payment: 10 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: TP |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 19961003 Year of fee payment: 10 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: PC2A Owner name: ACUFEX MICROSURGICAL, INC. |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732E |
|
NLS | Nl: assignments of ep-patents |
Owner name: ACUFEX MICROSURGICAL INC. |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19970811 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19970812 Ref country code: ES Free format text: THE PATENT HAS BEEN ANNULLED BY A DECISION OF A NATIONAL AUTHORITY Effective date: 19970812 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19970831 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19970831 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19970831 |
|
BERE | Be: lapsed |
Owner name: ACUFEX MICROSURGICAL INC. Effective date: 19970831 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19980301 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 19970811 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19980430 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19980501 |
|
EUG | Se: european patent has lapsed |
Ref document number: 87111585.3 |
|
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee |
Effective date: 19980301 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20001204 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20060831 Year of fee payment: 20 |